Xunxi Lu

5PUBLICATIONS
13CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 07, 2026
Integration of histopathological characteristics by machine learning improves the prediction of neoadjuvant immunochemotherapy response in triple-negative breast cancer.

Xunxi Lu, Bin Luo, Yani Wei

|Jan 23, 2025
Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer.

Xunxi Lu, Zongchao Gou, Hong Chen

|Aug 12, 2024
Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer.

Xunxi Lu, Zongchao Gou, Hong Chen

|Apr 14, 2023
An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression.

Xun-Xi Lu, Wen-Xiao Yang, Yu-Chen Pei

|Aug 19, 2021
PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.

Tian-Jian Yu, Ying-Ying Liu, Xiao-Guang Li

Pageof 1

Frequent Collaborators

1 joint publications

Zhi-Ming Shao

1 joint publications

Wen-Xiao Yang

1 joint publications

Yu-Chen Pei

1 joint publications

Hong Luo